Advertisement
Screener

Tilray Brands, Inc. (TLRY) Equity Securities, FV-NI, Unrealized Gain (Loss)

2.3 / 5 stars · 30/64 Roast Me

Tilray Brands, Inc. Equity Securities, FV-NI, Unrealized Gain (Loss)

Tilray Brands, Inc. (TLRY) reported Equity Securities, FV-NI, Unrealized Gain (Loss) of $21.66 million for the 12-month period ending 2025-05-31, per its 10-K filed 2025-07-29.

Financial Statements › Income Statement › Other Income

us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss · last filed 2025-07-29

  • Tilray Brands, Inc. equity securities, fv-ni, unrealized gain (loss) for the quarter ending 2025-05-31 was $41.66M, a 51.19% decline year-over-year.
  • Tilray Brands, Inc. equity securities, fv-ni, unrealized gain (loss) for the quarter ending 2024-05-31 was $85.36M.
  • Tilray Brands, Inc. equity securities, fv-ni, unrealized gain (loss) for the quarter ending 2022-02-28 was -$2.95M, a 1083.67% decline year-over-year.
  • Tilray Brands, Inc. equity securities, fv-ni, unrealized gain (loss) for the quarter ending 2021-11-30 was -$1.81M.
  • Tilray Brands, Inc. equity securities, fv-ni, unrealized gain (loss) for fiscal 2025 was $21.66M, a 49.25% decline from fiscal 2024.
  • Tilray Brands, Inc. equity securities, fv-ni, unrealized gain (loss) for fiscal 2024 was $42.68M.
Period endEquity Securities, FV-NI, Unrealized Gain (Loss) 3 monthEquity Securities, FV-NI, Unrealized Gain (Loss) 6 monthEquity Securities, FV-NI, Unrealized Gain (Loss) 9 monthEquity Securities, FV-NI, Unrealized Gain (Loss) 12 month
2025-05-31$41.66M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-29
$21.66M
10-K · filed 2025-07-29
2025-02-28-$20.00M
10-Q · filed 2025-04-08
2024-05-31$85.36M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-29
$42.68M
10-K · filed 2025-07-29
2024-02-29-$42.68M
10-Q · filed 2025-04-08
2022-02-28-$2.95M
10-Q · filed 2022-04-06
-$4.76M
derived: sum of 2 quarters · filed 2022-04-06
-$6.83M
10-Q · filed 2022-04-06
2021-11-30-$1.81M
10-Q · filed 2022-01-10
-$3.88M
10-Q · filed 2022-01-10
2021-03-31$300.00K
10-Q · filed 2021-05-10
2021-02-28-$1.92M
10-Q · filed 2022-04-06
-$2.32M
derived: sum of 2 quarters · filed 2022-04-06
-$3.24M
10-Q · filed 2022-04-06
2020-11-30-$399.00K
10-Q · filed 2022-01-10
-$1.33M
10-Q · filed 2022-01-10
2020-09-30-$506.00K
10-Q · filed 2020-11-09
$261.00K
derived: sum of 2 quarters · filed 2020-11-09
-$1.27M
10-Q · filed 2020-11-09
2020-06-30$767.00K
10-Q · filed 2020-08-10
-$767.00K
10-Q · filed 2020-08-10
2020-03-31-$1.53M
10-Q · filed 2021-05-10
2019-09-30-$274.00K
10-Q · filed 2020-11-09
$1.12M
derived: sum of 2 quarters · filed 2020-11-09
$264.00K
10-Q · filed 2020-11-09
2019-06-30$1.40M
10-Q · filed 2020-08-10
-$577.00K
10-Q · filed 2020-08-10
2019-03-31$1.40M
10-Q · filed 2020-05-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
Canopy Growth Corp (CGC)$0.395B
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87